Curative Effects for B-Cell Lymphoma Accomplished by Direct-Acting Antiviral Agents of Hepatitis C | Zendy

Nobuhiro Hattori | Zendy; Hiroki Ikeda | Zendy; Hiroyasu Nakano | Zendy; Nobuyuki Matsumoto | Zendy; Tsunamasa Watanabe | Zendy; Ryuta Shigefuku | Zendy; Y. Noguchi | Zendy; Kotaro Matsunaga | Zendy; Hirotaka Sakai | Zendy; Chiaki Okuse | Zendy; Hiroyuki Yamamoto | Zendy; Ikuo Miura | Zendy; Michihiro Suzuki | Zendy; Fumio Itoh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Curative Effects for B-Cell Lymphoma Accomplished by Direct-Acting Antiviral Agents of Hepatitis C

Author(s) -

Nobuhiro Hattori,

Hiroki Ikeda,

Hiroyasu Nakano,

Nobuyuki Matsumoto,

Tsunamasa Watanabe,

Ryuta Shigefuku,

Y. Noguchi,

Kotaro Matsunaga,

Hirotaka Sakai,

Chiaki Okuse,

Hiroyuki Yamamoto,

Ikuo Miura,

Michihiro Suzuki,

Fumio Itoh

Publication year - 2017

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofx057

Subject(s) - medicine , lymphoma , virology , hepatitis c , hepatitis b , immunology

Hepatitis C virus (HCV) is a hepatotropic and lymphotropic virus with the capabilities of tumorigenesis. We present an HCV-infected patient affected with B-cell lymphomas after suffering from hepatocellular carcinoma. The patient exhibited curative effects for lymphomas after treatment with sofosbuvir and ledipasvir, which is shown clearly with a positron emission tomography scanner.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research